ArticleAnnals of medicine and surgery (2012)2025
A case of tuberculous meningitis triggered by long-term use of corticosteroids drugs.
Article in Annals of medicine and surgery (2012), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction and importance: Tuberculous meningitis (TBM), caused by Case presentation: A 25-year-old woman from East Sudan presented with headache, neck pain, fever, anxiety, and hemodynamic instability. Despite no prior history of tuberculosis or known contact with affected individuals, her diagnosis of TBM was confirmed based on clinical presentation, radiological findings (notably leptomeningeal enhancement), and a positive response to anti-tuberculosis therapy. Clinical Discussion: This case highlights the importance of immunosuppressive therapy as a risk factor, as the patient had been on a prolonged course of corticosteroids (dexamethasone) at a dose of 15 mg/day for 6 months. This atypical presentation emphasizes the relevance of TBM in patients with prolonged symptoms of meningitis that do not respond to standard treatment, especially those with a history of immunocompromising diseases or drugs. Conclusion: This case demonstrates the serious implications of inappropriate corticosteroid usage, as well as the crucial importance of early diagnosis and treatment of TBM to avoid life-threatening complications. It serves as a reminder of the significance of remaining vigilant for TBM in areas where tuberculosis is endemic.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.